1.205USDMkt Cap: 12.63M USDP/E: —Last update: 2026-05-21
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detect…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Company
Market Cap12.63M USD
Enterprise Value9.49M USD
Revenue (TTM)1.84M USD
Gross Profit604.54K USD
Net Income (TTM)-3.74M USD
Revenue/Share0.3270 USD
Last Price1.205 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.42
EV/Revenue5.15
P/S6.85
P/B-100.42
EPS (TTM)-0.36
EPS (Forward)—
52W Range
1.19012% of range1.315
52W High1.315 USD
52W Low1.190 USD
Profitability
Gross Margin29.56%
Oper. Margin-408.45%
EBITDA Margin-212.60%
Profit Margin-182.82%
ROE19447.70%
ROA-90.37%
Growth
Revenue Growth-36.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.92M USD
CapEx (TTM)—
FCF Margin-70.58%
FCF Yield-10.31%
Net Debt-3.29M USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity-70.67
Current Ratio1.82
Quick Ratio1.71
Book Value/Sh-0.0120 USD
Cash/Share0.3980 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)5.000 USD
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.10.48M
Float8.66M
Insiders34.73%
Institutions2.83%
Short Interest
Short Ratio0.5d
Short % Float0.39%
Short % Out.0.32%
Shares Short33.12K
Short (prev mo.)54.25K
Technical
SMA 501.712 (-29.6%)
SMA 2002.770 (-56.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)78.63K
Avg Vol (10d)70.14K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—